SrasV1, PubMed, Checkpoint, bibRecord, 002281

Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.

Identifieur interne : 002281 ( PubMed/Checkpoint ); précédent : 002280; suivant : 002282

Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.

Auteurs : Noriyuki Kanzawa [Japon] ; Kazuo Nishigaki ; Takaya Hayashi ; Yuichi Ishii ; Souichi Furukawa ; Ayako Niiro ; Fumihiko Yasui ; Michinori Kohara ; Kouichi Morita ; Kouji Matsushima ; Mai Quynh Le ; Takao Masuda ; Mari Kannagi

Source :

FEBS letters [ 0014-5793 ] ; 2006.

RBID : pubmed:17141229

Descripteurs français

English descriptors

KwdEn :
- Cell Line, Chemokines (biosynthesis), Enzyme Activation, Gene Expression, Humans, JNK Mitogen-Activated Protein Kinases (metabolism), NF-kappa B (metabolism), Promoter Regions, Genetic (genetics), SARS Virus (genetics), SARS Virus (metabolism), Viral Matrix Proteins (genetics), Viral Matrix Proteins (metabolism), Viral Proteins (genetics), Viral Proteins (metabolism), Viral Structural Proteins (genetics), Viral Structural Proteins (metabolism).
MESH :
- chemical , biosynthesis : Chemokines.
- chemical , genetics : Viral Matrix Proteins, Viral Proteins, Viral Structural Proteins.
- chemical , metabolism : JNK Mitogen-Activated Protein Kinases, NF-kappa B, Viral Matrix Proteins, Viral Proteins, Viral Structural Proteins.
- genetics : Promoter Regions, Genetic, SARS Virus.
- metabolism : SARS Virus.
- Cell Line, Enzyme Activation, Gene Expression, Humans.

Abstract

Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS-CoV) tested, 3a/X1 and 7a/X4 were capable of activating nuclear factor kappa B (NF-kappaB) and c-Jun N-terminal kinase (JNK), and significantly enhanced interleukin 8 (IL-8) promoter activity. Furthermore, 3a/X1 and 7a/X4 expression in A549 cells enhanced production of inflammatory chemokines that were known to be up-regulated in SARS-CoV infection. Our results suggest potential involvement of 3a/X1 and 7a/X4 proteins in the pathological inflammatory responses in SARS.

DOI: 10.1016/j.febslet.2006.11.046
PubMed: 17141229

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001F71
to stream PubMed, to step Curation: 001F71

Links to Exploration step

pubmed:17141229

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.</title>
<author><name sortKey="Kanzawa, Noriyuki" sort="Kanzawa, Noriyuki" uniqKey="Kanzawa N" first="Noriyuki" last="Kanzawa">Noriyuki Kanzawa</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Immunotherapeutics, Tokyo Medical and Dental University, Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Immunotherapeutics, Tokyo Medical and Dental University, Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nishigaki, Kazuo" sort="Nishigaki, Kazuo" uniqKey="Nishigaki K" first="Kazuo" last="Nishigaki">Kazuo Nishigaki</name>
</author>
<author><name sortKey="Hayashi, Takaya" sort="Hayashi, Takaya" uniqKey="Hayashi T" first="Takaya" last="Hayashi">Takaya Hayashi</name>
</author>
<author><name sortKey="Ishii, Yuichi" sort="Ishii, Yuichi" uniqKey="Ishii Y" first="Yuichi" last="Ishii">Yuichi Ishii</name>
</author>
<author><name sortKey="Furukawa, Souichi" sort="Furukawa, Souichi" uniqKey="Furukawa S" first="Souichi" last="Furukawa">Souichi Furukawa</name>
</author>
<author><name sortKey="Niiro, Ayako" sort="Niiro, Ayako" uniqKey="Niiro A" first="Ayako" last="Niiro">Ayako Niiro</name>
</author>
<author><name sortKey="Yasui, Fumihiko" sort="Yasui, Fumihiko" uniqKey="Yasui F" first="Fumihiko" last="Yasui">Fumihiko Yasui</name>
</author>
<author><name sortKey="Kohara, Michinori" sort="Kohara, Michinori" uniqKey="Kohara M" first="Michinori" last="Kohara">Michinori Kohara</name>
</author>
<author><name sortKey="Morita, Kouichi" sort="Morita, Kouichi" uniqKey="Morita K" first="Kouichi" last="Morita">Kouichi Morita</name>
</author>
<author><name sortKey="Matsushima, Kouji" sort="Matsushima, Kouji" uniqKey="Matsushima K" first="Kouji" last="Matsushima">Kouji Matsushima</name>
</author>
<author><name sortKey="Le, Mai Quynh" sort="Le, Mai Quynh" uniqKey="Le M" first="Mai Quynh" last="Le">Mai Quynh Le</name>
</author>
<author><name sortKey="Masuda, Takao" sort="Masuda, Takao" uniqKey="Masuda T" first="Takao" last="Masuda">Takao Masuda</name>
</author>
<author><name sortKey="Kannagi, Mari" sort="Kannagi, Mari" uniqKey="Kannagi M" first="Mari" last="Kannagi">Mari Kannagi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:17141229</idno>
<idno type="pmid">17141229</idno>
<idno type="doi">10.1016/j.febslet.2006.11.046</idno>
<idno type="wicri:Area/PubMed/Corpus">001F71</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F71</idno>
<idno type="wicri:Area/PubMed/Curation">001F71</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001F71</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002281</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002281</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.</title>
<author><name sortKey="Kanzawa, Noriyuki" sort="Kanzawa, Noriyuki" uniqKey="Kanzawa N" first="Noriyuki" last="Kanzawa">Noriyuki Kanzawa</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Immunotherapeutics, Tokyo Medical and Dental University, Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Immunotherapeutics, Tokyo Medical and Dental University, Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nishigaki, Kazuo" sort="Nishigaki, Kazuo" uniqKey="Nishigaki K" first="Kazuo" last="Nishigaki">Kazuo Nishigaki</name>
</author>
<author><name sortKey="Hayashi, Takaya" sort="Hayashi, Takaya" uniqKey="Hayashi T" first="Takaya" last="Hayashi">Takaya Hayashi</name>
</author>
<author><name sortKey="Ishii, Yuichi" sort="Ishii, Yuichi" uniqKey="Ishii Y" first="Yuichi" last="Ishii">Yuichi Ishii</name>
</author>
<author><name sortKey="Furukawa, Souichi" sort="Furukawa, Souichi" uniqKey="Furukawa S" first="Souichi" last="Furukawa">Souichi Furukawa</name>
</author>
<author><name sortKey="Niiro, Ayako" sort="Niiro, Ayako" uniqKey="Niiro A" first="Ayako" last="Niiro">Ayako Niiro</name>
</author>
<author><name sortKey="Yasui, Fumihiko" sort="Yasui, Fumihiko" uniqKey="Yasui F" first="Fumihiko" last="Yasui">Fumihiko Yasui</name>
</author>
<author><name sortKey="Kohara, Michinori" sort="Kohara, Michinori" uniqKey="Kohara M" first="Michinori" last="Kohara">Michinori Kohara</name>
</author>
<author><name sortKey="Morita, Kouichi" sort="Morita, Kouichi" uniqKey="Morita K" first="Kouichi" last="Morita">Kouichi Morita</name>
</author>
<author><name sortKey="Matsushima, Kouji" sort="Matsushima, Kouji" uniqKey="Matsushima K" first="Kouji" last="Matsushima">Kouji Matsushima</name>
</author>
<author><name sortKey="Le, Mai Quynh" sort="Le, Mai Quynh" uniqKey="Le M" first="Mai Quynh" last="Le">Mai Quynh Le</name>
</author>
<author><name sortKey="Masuda, Takao" sort="Masuda, Takao" uniqKey="Masuda T" first="Takao" last="Masuda">Takao Masuda</name>
</author>
<author><name sortKey="Kannagi, Mari" sort="Kannagi, Mari" uniqKey="Kannagi M" first="Mari" last="Kannagi">Mari Kannagi</name>
</author>
</analytic>
<series><title level="j">FEBS letters</title>
<idno type="ISSN">0014-5793</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cell Line</term>
<term>Chemokines (biosynthesis)</term>
<term>Enzyme Activation</term>
<term>Gene Expression</term>
<term>Humans</term>
<term>JNK Mitogen-Activated Protein Kinases (metabolism)</term>
<term>NF-kappa B (metabolism)</term>
<term>Promoter Regions, Genetic (genetics)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (metabolism)</term>
<term>Viral Matrix Proteins (genetics)</term>
<term>Viral Matrix Proteins (metabolism)</term>
<term>Viral Proteins (genetics)</term>
<term>Viral Proteins (metabolism)</term>
<term>Viral Structural Proteins (genetics)</term>
<term>Viral Structural Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Activation enzymatique</term>
<term>Chimiokines (biosynthèse)</term>
<term>Expression des gènes</term>
<term>Facteur de transcription NF-kappa B (métabolisme)</term>
<term>Humains</term>
<term>JNK Mitogen-Activated Protein Kinases (métabolisme)</term>
<term>Lignée cellulaire</term>
<term>Protéines de la matrice virale (génétique)</term>
<term>Protéines de la matrice virale (métabolisme)</term>
<term>Protéines virales (génétique)</term>
<term>Protéines virales (métabolisme)</term>
<term>Protéines virales structurales (génétique)</term>
<term>Protéines virales structurales (métabolisme)</term>
<term>Régions promotrices (génétique) (génétique)</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Chemokines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Viral Matrix Proteins</term>
<term>Viral Proteins</term>
<term>Viral Structural Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>JNK Mitogen-Activated Protein Kinases</term>
<term>NF-kappa B</term>
<term>Viral Matrix Proteins</term>
<term>Viral Proteins</term>
<term>Viral Structural Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Chimiokines</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Promoter Regions, Genetic</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Protéines de la matrice virale</term>
<term>Protéines virales</term>
<term>Protéines virales structurales</term>
<term>Régions promotrices (génétique)</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Facteur de transcription NF-kappa B</term>
<term>JNK Mitogen-Activated Protein Kinases</term>
<term>Protéines de la matrice virale</term>
<term>Protéines virales</term>
<term>Protéines virales structurales</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cell Line</term>
<term>Enzyme Activation</term>
<term>Gene Expression</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Activation enzymatique</term>
<term>Expression des gènes</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS-CoV) tested, 3a/X1 and 7a/X4 were capable of activating nuclear factor kappa B (NF-kappaB) and c-Jun N-terminal kinase (JNK), and significantly enhanced interleukin 8 (IL-8) promoter activity. Furthermore, 3a/X1 and 7a/X4 expression in A549 cells enhanced production of inflammatory chemokines that were known to be up-regulated in SARS-CoV infection. Our results suggest potential involvement of 3a/X1 and 7a/X4 proteins in the pathological inflammatory responses in SARS.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17141229</PMID>
<DateCompleted><Year>2007</Year>
<Month>01</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0014-5793</ISSN>
<JournalIssue CitedMedium="Print"><Volume>580</Volume>
<Issue>30</Issue>
<PubDate><Year>2006</Year>
<Month>Dec</Month>
<Day>22</Day>
</PubDate>
</JournalIssue>
<Title>FEBS letters</Title>
<ISOAbbreviation>FEBS Lett.</ISOAbbreviation>
</Journal>
<ArticleTitle>Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.</ArticleTitle>
<Pagination><MedlinePgn>6807-12</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS-CoV) tested, 3a/X1 and 7a/X4 were capable of activating nuclear factor kappa B (NF-kappaB) and c-Jun N-terminal kinase (JNK), and significantly enhanced interleukin 8 (IL-8) promoter activity. Furthermore, 3a/X1 and 7a/X4 expression in A549 cells enhanced production of inflammatory chemokines that were known to be up-regulated in SARS-CoV infection. Our results suggest potential involvement of 3a/X1 and 7a/X4 proteins in the pathological inflammatory responses in SARS.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanzawa</LastName>
<ForeName>Noriyuki</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Immunotherapeutics, Tokyo Medical and Dental University, Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nishigaki</LastName>
<ForeName>Kazuo</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hayashi</LastName>
<ForeName>Takaya</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ishii</LastName>
<ForeName>Yuichi</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Furukawa</LastName>
<ForeName>Souichi</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Niiro</LastName>
<ForeName>Ayako</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yasui</LastName>
<ForeName>Fumihiko</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kohara</LastName>
<ForeName>Michinori</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Morita</LastName>
<ForeName>Kouichi</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Matsushima</LastName>
<ForeName>Kouji</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Le</LastName>
<ForeName>Mai Quynh</ForeName>
<Initials>MQ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Masuda</LastName>
<ForeName>Takao</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kannagi</LastName>
<ForeName>Mari</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2006</Year>
<Month>11</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>FEBS Lett</MedlineTA>
<NlmUniqueID>0155157</NlmUniqueID>
<ISSNLinking>0014-5793</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018925">Chemokines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C515313">ORF3A protein, SARS coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015678">Viral Structural Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C488151">sars7a protein, SARS virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048031">JNK Mitogen-Activated Protein Kinases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D048031" MajorTopicYN="N">JNK Mitogen-Activated Protein Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015678" MajorTopicYN="N">Viral Structural Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year>
<Month>09</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2006</Year>
<Month>11</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2006</Year>
<Month>11</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>12</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>1</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>12</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17141229</ArticleId>
<ArticleId IdType="pii">S0014-5793(06)01368-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.febslet.2006.11.046</ArticleId>
<ArticleId IdType="pmc">PMC7094718</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Clin Diagn Lab Immunol. 2005 Jul;12(7):848-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16002634</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3584-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8170951</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Physiol Lung Cell Mol Physiol. 2001 Nov;281(5):L1037-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11597894</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12927536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Mar;79(5):3182-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15709039</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2005 Jul;86(Pt 7):1921-1930</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15958670</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Natl Cancer Inst. 1973 Nov;51(5):1417-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4357758</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Blood. 2005 Oct 1;106(7):2366-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15860669</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Pathol. 2004 Feb;202(2):145-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14743496</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2005 Apr 29;330(1):286-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15781262</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Jul;71(7):5692-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9188651</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2006 May 19;343(4):1201-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16580632</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 1993 Sep 1;151(5):2601-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7689610</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2431-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14681510</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 2005 May;109(2):191-202</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15763150</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Leukoc Biol. 2002 Nov;72(5):847-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12429706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Dec;78(24):14043-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15564512</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2004 Jun 15;172(12):7841-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15187168</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Blood. 1995 Mar 15;85(6):1454-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7888668</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Am J Respir Med. 2002;1(1):19-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14720072</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Signal. 2000 Jan;12(1):1-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10676842</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781533</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Drug Discov. 2003 Jul;2(7):554-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12815381</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Mod Pathol. 2005 Nov;18(11):1432-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15920543</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2006 Mar;80(5):2326-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16474139</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Japon</li>
</country>
<region><li>Région de Kantō</li>
</region>
<settlement><li>Tokyo</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Furukawa, Souichi" sort="Furukawa, Souichi" uniqKey="Furukawa S" first="Souichi" last="Furukawa">Souichi Furukawa</name>
<name sortKey="Hayashi, Takaya" sort="Hayashi, Takaya" uniqKey="Hayashi T" first="Takaya" last="Hayashi">Takaya Hayashi</name>
<name sortKey="Ishii, Yuichi" sort="Ishii, Yuichi" uniqKey="Ishii Y" first="Yuichi" last="Ishii">Yuichi Ishii</name>
<name sortKey="Kannagi, Mari" sort="Kannagi, Mari" uniqKey="Kannagi M" first="Mari" last="Kannagi">Mari Kannagi</name>
<name sortKey="Kohara, Michinori" sort="Kohara, Michinori" uniqKey="Kohara M" first="Michinori" last="Kohara">Michinori Kohara</name>
<name sortKey="Le, Mai Quynh" sort="Le, Mai Quynh" uniqKey="Le M" first="Mai Quynh" last="Le">Mai Quynh Le</name>
<name sortKey="Masuda, Takao" sort="Masuda, Takao" uniqKey="Masuda T" first="Takao" last="Masuda">Takao Masuda</name>
<name sortKey="Matsushima, Kouji" sort="Matsushima, Kouji" uniqKey="Matsushima K" first="Kouji" last="Matsushima">Kouji Matsushima</name>
<name sortKey="Morita, Kouichi" sort="Morita, Kouichi" uniqKey="Morita K" first="Kouichi" last="Morita">Kouichi Morita</name>
<name sortKey="Niiro, Ayako" sort="Niiro, Ayako" uniqKey="Niiro A" first="Ayako" last="Niiro">Ayako Niiro</name>
<name sortKey="Nishigaki, Kazuo" sort="Nishigaki, Kazuo" uniqKey="Nishigaki K" first="Kazuo" last="Nishigaki">Kazuo Nishigaki</name>
<name sortKey="Yasui, Fumihiko" sort="Yasui, Fumihiko" uniqKey="Yasui F" first="Fumihiko" last="Yasui">Fumihiko Yasui</name>
</noCountry>
<country name="Japon"><region name="Région de Kantō"><name sortKey="Kanzawa, Noriyuki" sort="Kanzawa, Noriyuki" uniqKey="Kanzawa N" first="Noriyuki" last="Kanzawa">Noriyuki Kanzawa</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002281 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002281 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:17141229
   |texte=   Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:17141229" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.

Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki